| 1000 | 2313401 | Anxrr27 | Anxiety related response QTL 27 | | | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 4 | 33637803 | 61708341 | Rat | n/a | region | qtl |
| 1000 | 6478724 | Anxrr35 | Anxiety related response QTL 35 | | 0.00449 | defecation behavior trait (VT:0010462) | defecation measurement (CMO:0000997) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 6478766 | Anxrr47 | Anxiety related response QTL 47 | | 0.09637 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 6478769 | Anxrr48 | Anxiety related response QTL 48 | | 0.02514 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 12798520 | Anxrr55 | Anxiety related response QTL 55 | 4.45 | 0.01 | locomotor behavior trait (VT:0001392) | number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) | 4 | 29549895 | 112807890 | Rat | n/a | region | qtl |
| 1000 | 1578655 | Bmd11 | Bone mineral density QTL 11 | 11 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 4 | 24631874 | 69631874 | Rat | n/a | region | qtl |
| 1000 | 1300141 | Bp178 | Blood pressure QTL 178 | | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 6572939 | 37703537 | Rat | n/a | region | qtl |
| 1000 | 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 3043231 | 145254791 | Rat | n/a | region | qtl |
| 1000 | 10755501 | Bp390 | Blood pressure QTL 390 | 2.5 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 23850384 | 169318094 | Rat | n/a | region | qtl |
| 1000 | 619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 3043231 | 79575658 | Rat | n/a | region | qtl |
| 1000 | 8552801 | Bw143 | Body weight QTL 143 | 7.3 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 31825560 | 83531021 | Rat | n/a | region | qtl |
| 1000 | 8694374 | Bw155 | Body weight QTL 155 | 3.39 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 631209 | Bw2 | Body weight QTL2 | 4.2 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 6467693 | 43414792 | Rat | n/a | region | qtl |
| 1000 | 2303585 | Bw86 | Body weight QTL 86 | 4 | | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 12638974 | 57638974 | Rat | n/a | region | qtl |
| 1000 | 61415 | Eae11 | Experimental allergic encephalomyelitis QTL 11 | 2.9 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 33637803 | 37685319 | Rat | n/a | region | qtl |
| 1000 | 70222 | Eae2 | Experimental allergic encephalomyelitis QTL 2 | 4.3 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) | 4 | 18222187 | 37685319 | Rat | n/a | region | qtl |
| 1000 | 2316958 | Gluco58 | Glucose level QTL 58 | 10 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 7850904 | 182171018 | Rat | n/a | region | qtl |
| 1000 | 634323 | Hc2 | Hypercalciuria QTL 2 | 2.15 | | urine calcium amount (VT:0002985) | urine calcium excretion rate (CMO:0000763) | 4 | 1 | 42118977 | Rat | n/a | region | qtl |
| 1000 | 6909122 | Insul22 | Insulin level QTL 22 | 4.63 | | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 4 | 23991721 | 76238799 | Rat | n/a | region | qtl |
| 1000 | 8655961 | Kidm43 | Kidney mass QTL 43 | 18 | | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 4 | 34277932 | 99067150 | Rat | n/a | region | qtl |
| 1000 | 11530004 | Niddm71 | Non-insulin dependent diabetes mellitus QTL 71 | | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 31554484 | 51311866 | Rat | n/a | region | qtl |
| 1000 | 6909128 | Pancm4 | Pancreatic morphology QTL 4 | 11.35 | | pancreas mass (VT:0010144) | pancreas wet weight (CMO:0000626) | 4 | 23991721 | 76238799 | Rat | n/a | region | qtl |
| 1000 | 61412 | Pia2 | Pristane induced arthritis QTL 2 | 3.9 | | joint integrity trait (VT:0010548) | post-insult time to onset of experimental arthritis (CMO:0001450) | 4 | 18222187 | 61039065 | Rat | n/a | region | qtl |
| 1000 | 8552906 | Pigfal3 | Plasma insulin-like growth factor 1 level QTL 3 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 8655906 | Rf60 | Renal function QTL 60 | 3.8 | | blood creatinine amount (VT:0005328) | creatinine clearance (CMO:0000765) | 4 | 26654749 | 81874227 | Rat | n/a | region | qtl |
| 1000 | 8655949 | Rf62 | Renal function QTL 62 | 22 | | blood urea nitrogen amount (VT:0005265) | plasma urea nitrogen level (CMO:0000586) | 4 | 31825200 | 43414792 | Rat | n/a | region | qtl |
| 1000 | 9590304 | Scort17 | Serum corticosterone level QTL 17 | 4.96 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 8052189 | 53052189 | Rat | n/a | region | qtl |
| 1000 | 1354665 | Stl10 | Serum triglyceride level QTL 10 | 3.57 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 18222187 | 43414792 | Rat | n/a | region | qtl |
| 1000 | 1358203 | Stl19 | Serum triglyceride level QTL 19 | 2.8 | 0.002 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 3044017 | 64915903 | Rat | n/a | region | qtl |
| 1000 | 631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 3047807 | 55324857 | Rat | n/a | region | qtl |
| 1000 | 2302371 | Stl22 | Serum triglyceride level QTL 22 | 5.15 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 3044017 | 55791834 | Rat | n/a | region | qtl |
| 1000 | 631261 | Tcas3 | Tongue tumor susceptibility QTL 3 | 6.88 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 4 | 7342404 | 92484039 | Rat | n/a | region | qtl |
| 1000 | 7387227 | Uae40 | Urinary albumin excretion QTL 40 | 2.9 | 0.0052 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 4 | 16149941 | 61149941 | Rat | n/a | region | qtl |
| 1000 | 8552782 | Vie1 | Viral induced encephalitis QTL 1 | 26.4 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 31825560 | 83531021 | Rat | n/a | region | qtl |
| 1000 | 8552809 | Vie5 | Viral induced encephalitis QTL 5 | 25.3 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 31825560 | 83531021 | Rat | n/a | region | qtl |